AI-Native Scoping Reviews & Evidence Mapping

This review shows that tattooing is far more than cosmetic ink: it maps how tattoos can act as long-term biological exposures linked to inflammation, pigment migration, diagnostic confusion, allergic disease, and possible cancer signals, while also serving as powerful medical tools in reconstruction, localization, drug delivery, and wearable sensing. The full paper is worth reading because it turns a scattered and emotionally charged topic into a clinically useful evidence map of where tattooing helps, where it harms, and which risks, technologies, and unanswered questions matter most.

Statins are not just cholesterol drugs: across an enormous evidence base, this review shows how they may help protect healthspan and longevity by lowering recurrent vascular events and mortality, while also exposing the real trade-offs around diabetes risk, intolerance, and poor long-term adherence. The full paper is worth reading because it separates where statins most clearly extend durable cardiovascular protection from where the evidence becomes mixed, controversial, and potentially relevant to broader aging-related pathways such as inflammation, liver disease, and neurocognitive decline.

This paper shows that the age gap between spouses is not just a demographic detail, but a meaningful social and health signal linked to early childbirth, women’s mental health, intimate partner violence patterns, child outcomes, widowhood, and household power dynamics across very different societies. The full review is worth reading because it reveals where larger age gaps may increase vulnerability, where they paradoxically appear protective, and how modernization is reshaping one of the most overlooked structures inside marriage.

Retraction does not end the life of bad science — this review shows how misconduct-driven papers can keep shaping citations, clinical thinking, and public belief long after formal withdrawal. Drawing on 129 references, it maps why retractions fail, where the system breaks, and why the hidden afterlife of invalid research matters far more than most readers realize.

This paper shows that chronotype is not a trivial lifestyle preference, but a biologically meaningful pattern linked across a huge evidence base to mood, sleep, metabolism, behavior, and real-world performance. The full paper is worth reading because it clarifies how strongly eveningness clusters with risk, where the signal is most consistent, and whether aligning life with one’s internal clock could become a practical lever for better health and longevity.

The aim of this review is to synthesize the current scientific literature regarding the biological activities, clinical efficacy, and safety profile of guarana across human, animal, and in vitro models. The review utilises 167 original studies with 251199 total participants (topic deduplicated ΣN). The evidence map suggests that guarana has its clearest human signals in acute cognitive performance and metabolic regulation, alongside notable safety concerns at higher stimulant exposures. In particular, guarana-containing interventions were associated with body fat reductions of 5.53% at 4 weeks…

This paper shows that economic inequality is not just a background social problem, but a force linked to worse health, weaker trust, more violence, and poorer collective resilience. The full paper is worth reading because it shows how inequality affects real outcomes across medicine, behavior, and society, and why both personal hardship and the perception of unfairness seem to matter.

This paper shows that daylight saving time is not a harmless calendar ritual: the clock changes align with measurable spikes in mortality, suicide, cardiovascular events, sleep loss, and road danger, with the spring and autumn transitions carrying distinct risks. Read the full paper to see where the strongest signals emerge, which outcomes remain inconsistent, and why the evidence increasingly points toward ending biannual clock changes rather than treating them as a neutral social habit.

This paper shows that coffee is not a proven anti-aging therapy, yet the mapped evidence still suggests a biologically plausible link to longer survival through oxidative-stress and insulin/IGF-1 pathways, with human data pointing to modest benefit rather than clear harm. Read the full text to see where the real signal lies, which findings are only indirect or genotype-specific, and why the apparent longevity story of coffee is much more nuanced than popular health claims suggest.

Y chromosome loss emerges in this paper not as a passive marker of ageing, but as a potentially central male-specific biological signal linked to cardiovascular death, cancer progression, neurodegeneration, and immune dysfunction across a massive evidence base. The full paper is worth reading because it shows where this signal is strongest, how consistent it is across 1,048 original studies, and why LOY may become both a prognostic biomarker and a future therapeutic target.